Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity

Oligonucleotides

Volumn 18, Issue 4, 2008, Pages 365-374

  Shervington, Amal ^a   Patel, Rahima ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DOUBLE STRANDED RNA; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PACLITAXEL; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TEMOZOLOMIDE;

ARTICLE; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA TRANSCRIPTION; DOWN REGULATION; DRUG INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; HUMANS; PACLITAXEL; RNA, SMALL INTERFERING; TELOMERASE;

EID: 57349176190     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0128     Document Type: Article

References (28)

1. CAMPBELL, P.M., and SZYF M. (2003). Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogen 24, 17-24.
2. CANATELLA, P.J., KARR, J.F., PETROS, J.A., and PRAUSNITZ, M.R. (2001). Quantitative study of electroporation-mediated molecular uptake and cell viability. Biophys J. 80, 755-764.
3. CARLSON, L.L., PAGE, A.W., and BESTOR, T.H. (1992). Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev 6, 2536-2541.
4. CHI, J.T., CHANG, H.Y., WANG, N.N., CHANG, D.S., DUNPHY, N., and BROWN, P.O. (2003). Genome-wide view of gene silencing by small interfering RNAs, PNAS 100, 6343-6346.
5. DE MARZO, A.M., MARCHI, V.L., EPSTEIN, J.I., and NELSON, W.G. (1999). Proliferative infl ammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 155, 1985-1992.
6. DONG, C.K., MASUTOMI, K., and HAHN, W.C. (2005). Telomerase: regulation, function and transformation. Crit. Rev. Oncol. Hematol. 54, 85-93.
7. ELBASHIR, S.M., MARTINEZ, J., PATKANIOWSKA, A., LENDECKEL, W., and TUSCHL, T. (2001). Functional anatomy of siRNAs for mediating effi cient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
8. GONZALO, S., JACO, I., FRAGA, M. F., CHEN, T., LI, E., ESTELLER, M., and BLASCO, M.A. (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 8, 416-424.
9. GUILLERET, I., and BENHATTAR, J. (2003). Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp. Cell. Res. 289, 326-334.
10. GUO, X., WANG, W., ZHOU, F., LU, Z., FANG, R., JIA, F., BU, X., LI, R., ZHANG, B., WU, M., and WEI, L. (2008). siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma. Cancer Biol. Ther. 7, ahead of print.
11. ISSA, J.P., VERTINO, P.M., WU, J., CELANO, P., NELKIN, B.D., HAMILTON, S.R., and BAYLIN, S.B. (1993). Increased cytosine DNA-methyltransferase activity during colon cancer progression. J. Natl Cancer Inst. 85, 1235-1240.
12. JARVIS, R., and KING, A. (2003). Optimizing chemical transfection and electroporation of siRNAs. Ambion TechNotes 10, 12-15.
13. KANZAWA, T., GERMANO, I.M., KONDO, Y., ITO, H., KYO, S., and KONDO, S. (2003). Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Br. J. Cancer 89, 922-929.
14. KIM, N.W., PIATYSZEK, M.A., PROWSE, K.R., HARLEY, C.B., WEST, M.D., HO, P.L., COVIELLO, G.M., WRIGHT, W.E., WEINRICH, S.L., and SHAY, J.W. (1994). Specifi c association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
15. KITAGAWA, Y., KYO, S., TAKAKURA, M., KANAYA, T., KOSHIDA, K., NAMIKI, M., and INOUE, M. (2000). Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT. Clin. Cancer Res. 6, 2868-2875.
16. KIYOZUKA, Y. (2005). Correlation of telomerase activity and telomere length to chemosensitivity. Methods Mol. Med. 111, 97-108.
17. LEU, Y.W., RAHMATPANAH, F., SHI, H., WEI, S.H., LIU, J.C., YAN, P.S., and HUANG, T.H. (2003). Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res. 63, 6110-6115.
18. LIU, G., YUAN, X., ZENG, Z., TUNICI, P., NG, H., ABDULKADIR, I.R., LU, L., IRVIN, D., BLACK, K.L., and YU, J.S. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 5, 67-79.
19. LUCZAK, M.W., and JAGODZINSKI, P.P. (2006). The role of DNA methylation in cancer development. Folia Histochemica Et cytobiologica. 44, 143-154.
20. MCCABE, M.T., LOW, J.A., DAIGNAULT, S., IMPERIALE, M.J., WOJNO, K.J., and DAY, M.L. (2006). Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res. 66, 385-392.
21. OKANO, M., BELL, D.W., HABER, D.A., and LI, E. (1999). DNA methyltransferases dnmt3a and dnmt3b are essential for de novo methylation and mammalian development. Cell. 9, 247-257.
22. PATEL, R., SHERVINGTON, L., LEA, R., and SHERVINGTON, A. (2008). Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma. Brain Res. 1188, 173-181.
23. PENDINO, F., TARKANYI, I., DUDOGNON, C., HILLION, J., LANOTTE, M., ARADI, J., and SÉGAL-BENDIRDJIAN, E. (2006). Telomeres and telomerase: pharmacological targets for new anticancer strategies? Current Cancer Drug Targets 6, 147-180.
24. RHEE, I., BACHMAN, K.E., PARK, B.H., JAIR, K.W., YEN, R.W., SCHUEBEL, K.E., CUI, H., FEINBERG, A.P., LENGAUER, C., KINZLER, K.W., BAYLIN, S.B., AND VOGELSTEIN, B. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556.
25. SHAY, J.W., and WRIGHT, W.E. (2005). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis. 26, 867-874.
26. SHI, Y. (2003). Mammalian RNAi for the masses. Trends Genet. 9, 9-12.
27. UNTERBERGER, A., ANDREWS, S.D., WEAVER, I.C.G., and SZYF, M. (2006). DNA methyltransferase 1 knockdown activates a replication stress checkpoint. Mol. Cellul. Biol. 26, 7575-7586.
28. XIONG, Y., DOWDY, S.C., XUE, A., SHUJUAN, J., EBERHARDT, N.L., PODRATZ, K.C., and JIANG, S.W. (2005). Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol. Oncol. 96, 601-609.